Elsevier

Biochemical Pharmacology

Volume 49, Issue 10, 17 May 1995, Pages 1373-1379
Biochemical Pharmacology

Research paper
Evidence obtained using single hepatocytes for inhibition by the phospholipase C inhibitor U73122 of store-operated Ca2+ inflow

https://doi.org/10.1016/0006-2952(95)00050-AGet rights and content

Abstract

The ability of 1-[6-[[17β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122), an inhibitor of phospholipase C (Smith et al., J Pharmacol Exp Ther 253: 688–697, 1992), to inhibit agonist-stimulated and store-operated Ca2+ inflow in single hepatocytes was investigated with the aim of testing whether the activation of phospholipase C is a necessary step in the process of agonist-stimulated Ca2+ inflow in this cell type. U73122 inhibited the release of Ca2+ from intracellular stores and plasma membrane Ca2+ inflow induced by vasopressin. An inactive analogue of U73122, 1-[6-[[17β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidone-dione (U73433), did not inhibit vasopressin-induced release of Ca2+ from intracellular stores, but did partially inhibit Ca2+ inflow. Neither U73122 nor ‘inactive’ analogue U73433 inhibited the release of Ca2+ from intracellular stores when this was initiated by the photolysis of ‘caged’ guanosine (5′-[γ-thio]triphosphate (GTPγS) introduced to the cytoplasmic space by microinjection. However, both compounds inhibited GTPγS-stimulated Ca2+ inflow. U73122 also inhibited the actions of glycerophosphoryl-myo-inositol-4,5-diphosphate (GPIP2), a slowly-hydrolysed analogue of inositol 1,4,5-triphosphate (InsP3) which is released by photolysis of ‘caged’ 1-(α-glycerophosphoryl)-myo-inositol-4,5-diphosphate, P4(5)-1-(2-nitrophenyl) ethyl ester, and thapsigargin in stimulating Ca2+ inflow. U73122 did not inhibit GPIP2-stimulated release of Ca2+ from intracellular stores, but did partially inhibit the ability of thapsigargin to induce Ca2+ release. It is concluded that, while U73122 does inhibit phospholipase Cβ in hepatocytes, complete inhibition of this enzyme in situ requires an intracellular concentration of U73122 higher than that achieved in the present experiments. Moreover, both U73122 and ‘inactive’ analogue U73433 have one or possibly two additional sites of action. These are likely to be the hepatocyte plasma membrane Ca2+ inflow channel protein (or a protein involved in the activation of this channel by the InsP3-sensitive intracellular Ca2+ store), and a protein involved in thapsigargin action.

References (37)

  • AK Thompson et al.

    The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuro-blastoma cells

    J Biol Chem

    (1991)
  • DI Yule et al.

    U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells

    J Biol Chem

    (1992)
  • Y Tsunoda et al.

    Differential involvement of phospholipase A2/arachidonic acid and phospholipase C/phosphoinositol pathways during cholecystokinin receptor activated Ca2+ oscillations in pancreatic acini

    Biochem Biophys Res Commun

    (1993)
  • JPY Kao et al.

    Photo-chemically generated cytosolic calcium pulses and their detection by fluo-3

    J Biol Chem

    (1989)
  • CA Alter et al.

    U-73122 does not specifically inhibit phospholipase C in rat pancreatic islets and insulin-secreting beta-cell lines

    Life Sci

    (1994)
  • MJ Berridge

    Inositol trisphosphate and calcium signalling

    Nature (London)

    (1993)
  • SJ Taylor et al.

    Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteins

    Nature (London)

    (1991)
  • DE Clapham et al.

    New roles for G-protein βγ-dimers in transmembrane signalling

    Nature (London)

    (1993)
  • Cited by (0)

    View full text